Eliza W Beal1, Dmitry Tumin2, Jeffery Chakedis1, Erica Porter3, Dimitrios Moris1, Xu-Feng Zhang1, Mark Arnold4, Alan Harzman4, Syed Husain4, Carl R Schmidt1, Timothy M Pawlik5. 1. Division of Surgical Oncology, Department of Surgery, Wexner Medical Center, James Cancer Hospital, Solove Research Institute, Health Services Management and Policy, The Ohio State University, 395 W. 12th Ave., Suite 670, Columbus, OH, USA. 2. The Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, OH, USA. 3. Department of Quality and Patient Safety, Wexner Medical Center, The Ohio State University, Columbus, OH, USA. 4. Division of Colorectal Surgery, Department of Surgery, Wexner Medical Center, James Cancer Hospital, Solove Research Institute, The Ohio State University, Columbus, OH, USA. 5. Division of Surgical Oncology, Department of Surgery, Wexner Medical Center, James Cancer Hospital, Solove Research Institute, Health Services Management and Policy, The Ohio State University, 395 W. 12th Ave., Suite 670, Columbus, OH, USA. Tim.Pawlik@osumc.edu.
Abstract
BACKGROUND: Given the conflicting nature of reported risk factors for post-discharge venous thromboembolism (VTE) and unclear guidelines for post-discharge pharmacoprophylaxis, we sought to determine risk factors for 30-day post-discharge VTE after colectomy to predict which patients will benefit from post-discharge pharmacoprophylaxis. METHODS: Patients who underwent colectomy in the American College of Surgeons National Surgical Quality Improvement Project Participant Use Files from 2011 to 2015 were identified. Logistic regression modeling was used. Receiver-operating characteristic curves were used and the best cut-points were determined using Youden's J index (sensitivity + specificity - 1). Hosmer-Lemeshow goodness-of-fit test was used to test model calibration. A random sample of 30% of the cohort was used as a validation set. RESULTS: Among 77,823 cases, the overall incidence of VTE after colectomy was 1.9%, with 0.7% of VTE events occurring in the post-discharge setting. Factors associated with post-discharge VTE risk including body mass index, preoperative albumin, operation time, hospital length of stay, race, smoking status, inflammatory bowel disease, return to the operating room and postoperative ileus were included in logistic regression equation model. The model demonstrated good calibration (goodness of fit P = 0.7137) and good discrimination (area under the curve (AUC) = 0.68; validation set, AUC = 0.70). A score of ≥-5.00 had the maxim sensitivity and specificity, resulting in 36.63% of patients being treated with prophylaxis for an overall VTE risk of 0.67%. CONCLUSION: Approximately one-third of post-colectomy VTE events occurred after discharge. Patients with predicted post-discharge VTE risk of ≥-5.00 should be recommended for extended post-discharge VTE prophylaxis.
BACKGROUND: Given the conflicting nature of reported risk factors for post-discharge venous thromboembolism (VTE) and unclear guidelines for post-discharge pharmacoprophylaxis, we sought to determine risk factors for 30-day post-discharge VTE after colectomy to predict which patients will benefit from post-discharge pharmacoprophylaxis. METHODS:Patients who underwent colectomy in the American College of Surgeons National Surgical Quality Improvement Project Participant Use Files from 2011 to 2015 were identified. Logistic regression modeling was used. Receiver-operating characteristic curves were used and the best cut-points were determined using Youden's J index (sensitivity + specificity - 1). Hosmer-Lemeshow goodness-of-fit test was used to test model calibration. A random sample of 30% of the cohort was used as a validation set. RESULTS: Among 77,823 cases, the overall incidence of VTE after colectomy was 1.9%, with 0.7% of VTE events occurring in the post-discharge setting. Factors associated with post-discharge VTE risk including body mass index, preoperative albumin, operation time, hospital length of stay, race, smoking status, inflammatory bowel disease, return to the operating room and postoperative ileus were included in logistic regression equation model. The model demonstrated good calibration (goodness of fit P = 0.7137) and good discrimination (area under the curve (AUC) = 0.68; validation set, AUC = 0.70). A score of ≥-5.00 had the maxim sensitivity and specificity, resulting in 36.63% of patients being treated with prophylaxis for an overall VTE risk of 0.67%. CONCLUSION: Approximately one-third of post-colectomy VTE events occurred after discharge. Patients with predicted post-discharge VTE risk of ≥-5.00 should be recommended for extended post-discharge VTE prophylaxis.
Authors: Gilaad G Kaplan; Ellen P McCarthy; John Z Ayanian; Joshua Korzenik; Richard Hodin; Bruce E Sands Journal: Gastroenterology Date: 2008-01-10 Impact factor: 22.682
Authors: Zhobin Moghadamyeghaneh; Reza Fazl Alizadeh; Mark H Hanna; Grace Hwang; Joseph C Carmichael; Steven Mills; Alessio Pigazzi; Michael J Stamos Journal: World J Surg Date: 2016-05 Impact factor: 3.352
Authors: K Kröger; D Weiland; C Ose; N Neumann; S Weiss; C Hirsch; K Urbanski; S Seeber; M E Scheulen Journal: Ann Oncol Date: 2005-11-09 Impact factor: 32.976
Authors: Jeanette W Chung; Mila H Ju; Christine V Kinnier; Elliott R Haut; David W Baker; Karl Y Bilimoria Journal: BMJ Qual Saf Date: 2014-08-18 Impact factor: 7.035
Authors: William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell Journal: Chest Date: 2008-06 Impact factor: 9.410
Authors: Philip Smart; Kate Burbury; Senthil Lingaratnam; A Craig Lynch; John Mackay; Alexander Heriot Journal: ANZ J Surg Date: 2012-09-17 Impact factor: 1.872
Authors: Cary Jo R Schlick; Jessica Y Liu; Anthony D Yang; David J Bentrem; Karl Y Bilimoria; Ryan P Merkow Journal: J Gastrointest Surg Date: 2019-08-16 Impact factor: 3.452
Authors: Cary Jo R Schlick; Tarik K Yuce; Anthony D Yang; Michael F McGee; David J Bentrem; Karl Y Bilimoria; Ryan P Merkow Journal: Surgery Date: 2020-10-17 Impact factor: 3.982